Home/Filings/4/0001193125-25-282918
4//SEC Filing

Shao Wei-Ming 4

Accession 0001193125-25-282918

CIK 0001050446other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 4:05 PM ET

Size

45.2 KB

Accession

0001193125-25-282918

Insider Transaction Report

Form 4
Period: 2025-11-12
Shao Wei-Ming
EVP & General Counsel
Transactions
  • Sale

    Class A Common Stock

    2025-11-12$221.90/sh511$113,39137,240 total
  • Sale

    Class A Common Stock

    2025-11-12$222.92/sh629$140,21836,611 total
  • Sale

    Class A Common Stock

    2025-11-12$226.00/sh342$77,29234,689 total
  • Exercise/Conversion

    Class A Common Stock

    2025-11-12$40.46/sh+20,000$809,20032,726 total
  • Exercise/Conversion

    Class A Common Stock

    2025-11-12$69.12/sh+5,334$368,70238,060 total
  • Sale

    Class A Common Stock

    2025-11-12$220.62/sh309$68,17137,751 total
  • Sale

    Class A Common Stock

    2025-11-12$224.06/sh727$162,89535,884 total
  • Sale

    Class A Common Stock

    2025-11-12$224.77/sh853$191,72835,031 total
  • Sale

    Class A Common Stock

    2025-11-12$227.02/sh455$103,29634,234 total
  • Sale

    Class A Common Stock

    2025-11-12$231.70/sh187$43,32833,690 total
  • Sale

    Class A Common Stock

    2025-11-12$234.43/sh126$29,53832,726 total
  • Exercise/Conversion

    Class A Common Stock

    2025-11-13$69.12/sh+2,600$179,72035,326 total
  • Sale

    Class A Common Stock

    2025-11-12$227.89/sh111$25,29634,123 total
  • Sale

    Class A Common Stock

    2025-11-12$233.76/sh490$114,54332,852 total
  • Sale

    Class A Common Stock

    2025-11-13$223.67/sh2,600$581,53432,726 total
  • Sale

    Class A Common Stock

    2025-11-12$229.20/sh48$11,00234,075 total
  • Sale

    Class A Common Stock

    2025-11-12$230.44/sh198$45,62733,877 total
  • Sale

    Class A Common Stock

    2025-11-12$232.96/sh348$81,07133,342 total
  • Exercise/Conversion

    Employee Stock Option (Right to buy)

    2025-11-1220,00079,100 total
    Exercise: $40.46Exp: 2032-02-17Class A Common Stock (20,000 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to buy)

    2025-11-125,334183,998 total
    Exercise: $69.12Exp: 2031-02-23Class A Common Stock (5,334 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to buy)

    2025-11-132,600181,398 total
    Exercise: $69.12Exp: 2031-02-23Class A Common Stock (2,600 underlying)
Holdings
  • Series A Perpetual Strife Preferred Stock

    500
  • Series A Perpetual Stretch Preferred Stock

    15,000
  • Series A Perpetual Stride Preferred Stock

    3,527
Footnotes (19)
  • [F1]The transactions reported were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on July 11, 2025. As previously disclosed in Strategy Inc's ("Strategy") Current Report on Form 8-K filed with the Securities and Exchange Commission ("SEC") on July 1, 2025, the reporting person informed the issuer of his intention to retire effective December 31, 2025.
  • [F10]The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.81 to $229.77, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  • [F11]The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.02 to $231.00, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  • [F12]The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.27 to $232.05, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  • [F13]The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.27 to $233.26, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  • [F14]The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $233.32 to $234.27, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  • [F15]The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.34 to $234.80, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  • [F16]The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.10 to $224.04, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  • [F17]The 20,000 shares exercised on November 12, 2025 pursuant to this option vested on February 17, 2025. Of the remaining 79,100 shares subject to this option, 29,100 shares vested on February 17, 2025 and 50,000 shares are scheduled to vest on February 17, 2026.
  • [F18]The 5,334 shares exercised on November 12, 2025 pursuant to this option vested on February 23, 2022. Of the remaining 183,998 shares subject to this option, 33,998 shares vested on February 23, 2022, 50,000 shares vested on February 23, 2023, 50,000 shares vested on February 23, 2024 and 50,000 shares vested on February 23, 2025.
  • [F19]The 2,600 shares exercised on November 13, 2025 pursuant to this option vested on February 23, 2022. Of the remaining 181,398 shares subject to this option, 31,398 shares vested on February 23, 2022, 50,000 shares vested on February 23, 2023, 50,000 shares vested on February 23, 2024 and 50,000 shares vested on February 23, 2025.
  • [F2]The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.235 to $221.115, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  • [F3]The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.37 to $222.240, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  • [F4]The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.430 to $223.426, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  • [F5]The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.446 to $224.415, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  • [F6]The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.45 to $225.448, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  • [F7]The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.505 to $226.460, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  • [F8]The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.56 to $227.50, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  • [F9]The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.665 to $228.03, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.

Documents

1 file

Issuer

Strategy Inc

CIK 0001050446

Entity typeother

Related Parties

1
  • filerCIK 0001663488

Filing Metadata

Form type
4
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:05 PM ET
Size
45.2 KB